Nutrient Loaded Glyconanoparticle Formulation Service
Overview
The fusion of nanotechnology and nutrition has ignited considerable enthusiasm across medicine, nutrition, and beyond. By leveraging glyconanoparticles, the researchers have seen advancements in enhancing bioavailability, achieving controlled nutrient release, improving stability, and numerous other benefits. As a premier manufacturer and supplier of glyconanoparticles, CD BioGlyco has established the cutting-edge GlycoNano™ Platform, offering an unparalleled nutrient-loaded glyconanoparticle formulation service to researchers globally. We stay at the forefront of nanotechnology innovations, fueling the progress of nutrient applications in diverse fields.
Innovative and Ecellent Nutrient-Loaded Glyconanoparticle Formulation Service
Our customizable solutions for glyconanoparticle formulation design, characterization, delivery analysis, and preclinical studies include the following:
Glyconanoparticle Development
We understand the specific needs of our clients, including the required nutrients, the type and size of the glyconanoparticle, the release characteristics, etc. After that, we design the glyconanoparticle formulation according to the requirements and prepare glyconanoparticles that load nutrients efficiently. We also optimize the formulation, such as adjusting the ratio of ingredients, changing the preparation conditions, etc., in order to improve the stability, loading capacity, and bioavailability of the glyconanoparticles. Developable glyconanoparticles include the following:
| Types of Glyconanoparticles | |
|---|---|
Glyconanoparticle Characterization
We use various characterization techniques (e.g., particle size analysis, morphological observation, spectral analysis, etc.) to characterize the Physicochemical Properties and Interactions of the prepared glyconanoparticle to provide detailed information for glyconanoparticle application information, which includes the following:
- Size and shape analysis: Techniques such as dynamic light scattering (DLS), and scanning electron microscopy (SEM) are used to examine the size and shape of glyconanoparticles.
- Zeta potential: Surface charge affects the stability and interaction of glyconanoparticles. We examine the zeta potential of the prepared glyconanoparticles.
- Chemical structure: Functional groups and molecular structure are examined to ensure the accuracy of the glyconanoparticle.
- Interactions: The binding affinity of the glyconanoparticle and its interactions with various active substances (lipids, proteins, carbohydrates, etc.) are analyzed in detail.
- Encapsulation efficiency: We measure the percentage of encapsulation of nutrients to provide valid information for research on the application of glyconanoparticles in the delivery of nutrients.
Glyconanoparticle Preclinical Studies
This process involves utilizing various in vivo and in vitro models to study the safety, stability, pharmacokinetics, etc.,of glyconanoparticles.
| Topic | Service | |
|---|---|---|
| Stability Study | ||
| Biological Characterization | ||
| Pharmacodynamic Study |
|
|
| Pharmacokinetic Study |
|
|
| Safety Pharmacology |
|
|
Nutrient Loaded Glyconanoparticle Formulation
Our Glyconanoparticle Formulation Service is available for the following types of nutrients.
![]() |
Vitamin Loaded Glyconanoparticle Formulation Service We offer a highly specialized vitamin-loaded glyconanoparticle formulation service and develop vitamin-loaded glyconanoparticles that effectively improve the stability and bioavailability of vitamins. Our goal is to provide reliable experimental support for the preparation of nutritional supplements with excellent properties and a wide range of applications. |
![]() |
Mineral Loaded Glyconanoparticle Formulation Service This service focuses on the development of glyconanoparticles that encapsulate various minerals, and we carefully design glyconanoparticle formulations to efficiently load minerals onto sugar nanoparticles under stringent formulation design and preparation processes, resulting in novel nutritional supplements with excellent stability, bioavailability, and targeted delivery capabilities. Through rigorous characterization and preclinical studies, we ensure that we obtain stable, reliable, and efficient mineral-loaded glyconanoparticle products. |
![]() |
Essential Fatty Acid Loaded Glyconanoparticle Formulation Service We use advanced nanotechnology to prepare glyconanoparticles for the encapsulation of essential fatty acids, a process that includes raw material selection, formulation optimization, glyconanoparticle preparation, full characterization, and preclinical studies. The entire process is carried out according to stringent quality standards to ensure that the quality and performance of the final product meet the specific needs of the client. |
![]() |
Probiotics Loaded Glyconanoparticle Formulation Service We provide a one-stop probiotics-loaded glyconanoparticle formulation service. Through the design of rational glyconanoparticles and the use of efficient and stable loading technology, we load probiotics onto glyconanoparticles to produce new probiotic products with unique performance and application value. Our researchers are skilled in modern biotechnology, nanotechnology, and materials science, and provide customized experimental solutions. |
![]() |
Prebiotics Loaded Glyconanoparticle Formulation Service Our prebiotics-loaded glyconanoparticle formulation service combines a variety of nanotechnology and characterization methods to provide new ideas and approaches for the application of prebiotic products. By developing glyconanoparticles that efficiently encapsulate prebiotics, we facilitate the preparation of new functional foods or nutritional supplements with unique health benefits. |
![]() |
Dietary Fiber Loaded Glyconanoparticle Formulation Service In this service, combining cutting-edge nanotechnology, we develop high-performance glyconanoparticles on which dietary fiber is loaded. This strategy significantly improves the stability, bioavailability, and targeted delivery of dietary fiber in the body, thereby contributing to various health benefits. |
![]() |
Antioxidant Loaded Glyconanoparticle Formulation Service We offer a customized antioxidant-loaded glyconanoparticle formulation service with innovative solutions. Combining cutting-edge nanotechnology, we develop high-performance glyconanoparticles and load them with dietary fiber. |
Workflow
We have in-depth communication with our clients to understand the type of nutrient they wish to load, the expected glyconanoparticle properties, and the target application areas. Based on these requirements, we carry out rational formulation design and prepare glyconanoparticle as a carrier for effective nutrient loading, and to ensure the quality of the product, we carry out detailed characterization and preclinical studies with various advanced characterization techniques. In the end, in addition to the products and detailed experimental reports, we also provide necessary technical support and after-sales service.

Applications
- In nutraceuticals, glyconanoparticles are developed for encapsulating vitamins, minerals, etc., to enhance their bioavailability and potency.
- In biopharmaceuticals, glyconanoparticles are developed to enhance therapeutic efficacy by loading and efficiently delivering nutrients such as minerals.
- In animal husbandry, glyconanoparticles are developed to significantly improve the utilization of nutrients by loading them to increase production.
Advantages
- We customize glyconanoparticles for specific nutrient types and targeted delivery mechanisms.
- We rationalize the controlled release profile of glyconanoparticles to extend nutrient availability.
- Comprehensive characterization and preclinical studies ensure the quality, functionality, and applicability of the developed glyconanoparticle.
Publication Data
Technology: Bottom-up approach
Journal: Nanomaterials
IF: 4.324
Published: 2019
Results: This paper describes the application of nanotechnology in dietary supplements. Nanoparticles, which can be prepared by either a bottom-up approach or top-down approach utilizing inorganic and organic materials, are used in various delivery strategies and to enhance the oral bioavailability of different types of nutraceuticals (bioactive peptides, fatty acids, micronutrients, etc.). These nanopreparations stabilize and enhance the functionality of nutraceuticals in food.
Fig.1 Most commonly used types of nanoformulations. (Jampilek, et al., 2019)
Frequently Asked Questions
- How does glyconanoparticle enhance nutrient delivery?
Glyconanoparticles contain specific sugar molecules that are recognized by specific targets, ensuring that nutrients are delivered exactly where they are needed most. It is also used to release nutrients gradually, which not only improves their stability but also ensures a continuous and controlled supply to the body. For difficult-to-solubilize nutrients, solubility and bioavailability are improved by encapsulating them in the glyconanoparticle. Glyconanoparticles can also carry multiple nutrients in a single formulation, allowing for synergistic combinations of nutritional supplements to be prepared. - How to start a nutrient-loaded glyconanoparticle formulation service?
Feel free to contact us through our website or client service with information about your research needs, intended applications, etc. Our service staff will contact you the first time and further communicate the detailed experimental requirements. After that, we will make a detailed experimental schedule and start the relevant experiments according to strict specifications.
At CD BioGlyco, we offer custom nutrient-loaded glyconanoparticle formulation services to tailor glyconanoparticles for specific applications, nutrient types, and target release profiles. Each project is developed collaboratively based on your needs. Please feel free to contact us for more detailed lab information.
Reference
- Jampilek, J.; et al. Potential of nanomaterial applications in dietary supplements and foods for special medical purposes. Nanomaterials. 2019, 9(2): 296.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform












